siRNA, Anti-FBXO9, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT71256WQ-2OMe)

The product SIRGT71256WQ-2OMe is a type of small interfering RNA (siRNA) that targets FBXO9 gene and regulates the expression of gene. The siRNA interferes with the expression of FBXO9 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_033481.3
Alternative Names FBX9; NY-REN-57; VCIA1; dJ341E18.2
Related Diseases Myoclonic Juvenile
Purification HPLC
Target Gene
Gene ID 26268
Uniprot ID Q9UK97
Sub Cat Target Species Modification Scale  
SIRGT72256WQ-2F FBXO9 Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT73256WQ-2MOE FBXO9 Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT74256WQ-LNA FBXO9 Human Locked Nucleic Acid (LNA) Inquiry
SIRGT71256WQ-RB FBXO9 Human Ribo-modified Inquiry
SIRGT72256WQ-BB FBXO9 Human Backbone-modified Inquiry

Related Products